News

Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced that it has entered into a definitive merger agreement to be acquired by Siemens Healthineers AG. Under the terms of the merger agreement, Siemens...

ScottCare Cardiovascular Solutions and the EP Heart Cardiovascular Electrophysiology Training Program at The University of Texas Health Science Center at Houston (UTHealth) announced a collaboration intended to provide an intensive training...

Researchers have found that a simple standardized approach for atrial fibrillation (AF) patients undergoing surgery has led to improved outcomes, according to a study in the latest issue of JAMA Internal Medicine. Feinstein Institutes for...

Access Point Technologies EP Inc. and Alterra Medical announced a strategic distribution partnership allowing Alterra Medical to distribute the complete line of APT EP Map-iT® Diagnostic Mapping Catheters.  Map-iT® Diagnostic Mapping...

A new Mayo Clinic research study shows that artificial intelligence (AI) can detect the signs of an irregular heart rhythm — atrial fibrillation (AF) — in an electrocardiogram (EKG), even if the heart is in normal rhythm at the time of a...

Adagio Medical, Inc., the developer of iCLAS™, the company's ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias, announces that the first PsAF patient was successfully treated with its...

HeartHero announces the closing of its oversubscribed Series A funding round. This funding secures a pathway for Elliot, an industry disruptive automated external defibrillator (AED), to be submitted for FDA Class III approval and CE mark....

SentreHEART, Inc., announced it has successfully completed nine First-In-Human procedures utilizing the LARIAT® with EpiRAIL™ at John Paul II hospital in Krakow, Poland. The LARIAT with EpiRAIL is an epicardial-only, percutaneous approach to...

Atrial fibrillation is a common abnormal heart rhythm. It is treated either with medications or by applying heat or extreme cold to destroy small specific tissue areas in the atrium. This inevitably causes small wounds. A team at the Cardiac...

Correvio Pharma Corp., a specialty pharmaceutical company focused on commercializing hospital drugs, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for Brinavess™...